Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Flip the coin: IL-7 and IL-7R in health and disease
  2. Barata, Joao T.; Durum,Scott; Seddon, Benedict
  3. Nature immunology. 2019, Dec; 20(12): 1584-1593.
  1. 2.   Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge
  2. Dobrovolskaia, M. A.; Patri, A. K.; Potter, T. M.; Rodriguez, J. C.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine. 2012, Feb; 7(2): 245-256.
  1. 3.   Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1
  2. Berquam-Vrieze, K. E.; Swing, D. A.; Tessarollo, L.; Dupuy, A. J.
  3. Genesis. 2012, Feb; 50(2): 112-118.
  1. 4.   Increased CD4(+) T Cell Levels during IL-7 Administration of Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Positive Macaques Are Not Dependent on Strong Proliferative Responses
  2. Leone, A.; Rohankhedkar, M.; Okoye, A.; Legasse, A.; Axthelm, M. K.; Villinger, F.; Piatak, M.; Lifson, J. D.; Assouline, B.; Morre, M.; Picker, L. J.; Sodora, D. L.
  3. Journal of Immunology. 2010, Aug; 185(3): 1650-1659.
  1. 5.   Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines
  2. Nagel, S.; Venturini, L.; Marquez, V. E.; Meyer, C.; Kaufmann, M.; Scherr, M.; MacLeod, R. A. F.; Drexler, H. G.
  3. Molecular Cancer. 2010, Jun; 9: 12.
  1. 6.   The molecular pathology of cancer
  2. Harris, T. J. R.; McCormick, F.
  3. Nature Reviews Clinical Oncology. 2010, May; 7(5): 251-265.
  1. 7.   Hematopoietic Immortalizing Function of the NKL-Subclass Homeobox Gene TLX1
  2. Renn, L. A. Z.; Hawley, T. S.; Burkett, S.; Ramezani, A.; Riz, I.; Adlers, R. L.; Hickstein, D. D.; Hawley, R. G.
  3. Genes Chromosomes & Cancer. 2010, Feb; 49(2): 119-131.
  1. 8.   Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive of the Leukemias Induced in SCID-X1 Patients Following Retroviral Gene Therapy
  2. Dave, U. P.; Akagi, K.; Tripathi, R.; Clevel, S. M.; Thompson, M. A.; Yi, M.; Stephens, R.; Downing, J. R.; Jenkins, N. A.; Copeland, N. G.
  3. Plos Genetics. 2009 5(5): 1-13.
  1. 9.   Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
  2. Lauchle, J. O.; Kim, D.; Le, D. T.; Akagi, K.; Crone, M.; Krisman, K.; Warner, K.; Bonifas, J. M.; Li, Q.; Coakley, K. M.; Diaz-Flores, E.; Gorman, M.; Przybranowski, S.; Tran, M.; Kogan, S. C.; Roose, J. P.; Copeland, N. G.; Jenkins, N. A.
  3. Nature. 2009 461(7262): 411-U110.
  1. 10.   Environmental genotoxicants/carcinogens and childhood cancer: Bridgeable gaps in scientific knowledge
  2. Anderson, L. M.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2006, Sep; 608(2): 136-156.
  1. 11.   Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
  2. Du, Y.; Jenkins, N. A.; Copeland, N. G.
  3. Blood. 2005, DEC 1; 106(12): 3932-3939.
  1. 12.   Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 162-174.
  1. 13.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 14.   Epigenetic and gene expression changes related to transgenerational carcinogenesis
  2. Cheng, R. Y. S.; Hockman, T.; Crawford, E.; Anderson, L. M.; Shiao, Y. H.
  3. Molecular Carcinogenesis. 2004 40(1): 1-11.
  1. 15.   Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas
  2. Warming, S.; Suzuki, T.; Yamaguchi, T. P.; Jenkins, N. A.; Copeland, N. G.
  3. Oncogene. 2004 23(15): 2727-2731.
  1. 17.   Characterization of an interleukin-7-dependent thymic cell line derived from a p53(-/-) mouse
  2. Kim, K.; Khaled, A. R.; Reynolds, D.; Young, H. A.; Lee, C. K.; Durum, S. K.
  3. Journal of Immunological Methods. 2003 274(1-2): 177-184.
  1. 19.   Testing of new agents in childhood cancer preclinical models: Meeting summary
  2. Houghton, P. J.; Adamson, P. C.; Blaney, S.; Fine, H. A.; Gorlick, R.; Haber, M.; Helman, L.; Hirschfeld, D.; Hollingshead, M. G.; Israel, M. A.; Lock, R. B.; Maris, J. M.; Merlino, G.; Patterson, W.; Reynolds, C. P.; Shannon, K.; Yu, A.; Yu, J.; Smith, M. A.
  3. Clinical Cancer Research. 2002 8(12): 3646-3657.
  1. 20.   Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS- related lymphoma
  2. Sei, S.; O'Neill, D. P.; Stewart, S. K.; Yang, Q. E.; Kumagai, M.; Boler, A. M.; Adde, M. A.; Zwerski, S. L.; Wood, L. V.; Venzon, D. J.; Magrath, I. T.
  3. Cancer Research. 2001, Jul; 61(13): 5028-5037.
  1. 22.   Workshop to identify critical windows of exposure for children's health: Cancer work group summary
  2. Olshan, A. F.; Anderson, L.; Roman, E.; Fear, N.; Wolff, M.; Whyatt, R.; Vu, V.; Diwan, B. A.; Potischman, N.
  3. Environmental Health Perspectives. 2000 108(Suppl 3): 595-597.
  1. 23.   Leukemia and lymphoma incidence in rodents exposed to low-frequency magnetic fields
  2. Boorman, G. A.; Rafferty, C. N.; Ward, J. M.; Sills, R. C.
  3. Radiation Research. 2000 153(5 Part 2): 627-636.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel